603222 Stock Overview
Researches, develops, produces, and sells human medicines and medical devices in China and internationally. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Chimin Health Management Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥6.40 |
52 Week High | CN¥9.33 |
52 Week Low | CN¥4.70 |
Beta | -0.063 |
1 Month Change | -17.42% |
3 Month Change | -0.62% |
1 Year Change | -16.78% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -41.18% |
Recent News & Updates
Recent updates
Shareholder Returns
603222 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -5.7% | -3.6% | -4.1% |
1Y | -16.8% | -6.0% | 6.9% |
Return vs Industry: 603222 underperformed the CN Pharmaceuticals industry which returned -6.5% over the past year.
Return vs Market: 603222 underperformed the CN Market which returned 6.4% over the past year.
Price Volatility
603222 volatility | |
---|---|
603222 Average Weekly Movement | 6.8% |
Pharmaceuticals Industry Average Movement | 6.4% |
Market Average Movement | 7.7% |
10% most volatile stocks in CN Market | 11.6% |
10% least volatile stocks in CN Market | 4.9% |
Stable Share Price: 603222 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603222's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 1,947 | Yunfei Tian | www.chimin.cn |
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells human medicines and medical devices in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products.
Chimin Health Management Co., Ltd. Fundamentals Summary
603222 fundamental statistics | |
---|---|
Market cap | CN¥3.36b |
Earnings (TTM) | -CN¥82.14m |
Revenue (TTM) | CN¥899.55m |
3.7x
P/S Ratio-40.9x
P/E RatioIs 603222 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603222 income statement (TTM) | |
---|---|
Revenue | CN¥899.55m |
Cost of Revenue | CN¥523.90m |
Gross Profit | CN¥375.65m |
Other Expenses | CN¥457.79m |
Earnings | -CN¥82.14m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 26, 2025
Earnings per share (EPS) | -0.16 |
Gross Margin | 41.76% |
Net Profit Margin | -9.13% |
Debt/Equity Ratio | 26.6% |
How did 603222 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 04:27 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chimin Health Management Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Xiaolan Bai | Guotai Junan Securities |
Ruibin Chen | Soochow Securities International Brokerage |